McAllister Matthew W, Aaronson Patrick, Spillane Joe, Schreiber Mark, Baroso Genelyn, Kraemer Dale, Smotherman Carmen, Gray-Eurom Kelly
Department of Pharmacy, University of Florida Health Science Center Jacksonville, 655 West 8th Street, Jacksonville, FL 32209.
Department of Pharmacy, University of Florida Health Science Center Jacksonville, 655 West 8th Street, Jacksonville, FL 32209.
Am J Emerg Med. 2015 Jun;33(6):781-5. doi: 10.1016/j.ajem.2015.03.036. Epub 2015 Mar 18.
In 2009, Florida initiated a statewide prescription drug-monitoring program (PDMP) to encourage safer prescribing of controlled substances and reduce drug abuse and diversion. Data supporting the utility of such programs in the emergency department (ED) is scarce. This study sought to determine the effect of PDMP data on controlled substance prescribing from the ED.
In this pre-post study utilizing a historical control, pharmacists in the ED provided prescribers with a summary of the PDMP data for their patients. The number of controlled substances prescribed in the intervention group was compared with that prescribed in the historical control to determine if the intervention resulted in a change in the average number of controlled substance prescribed.
Among the 710 patients evaluated, providing prescribers with PDMP data did not alter the average number of controlled substance per patient prescribed (0.23 controlled substances per patient in the historical control compared with 0.28 controlled substances per patient in the intervention group; 95% confidence interval [CI], -0.016 to 0.116; P = .125). All prescribers surveyed indicated that having PDMP data altered their controlled substance prescribing and felt more comfortable prescribing controlled substances.
Although the results did not demonstrate a change in the average number of controlled substances prescribed when prescribers were provided with PDMP data, results from the survey indicate that prescribers felt the data altered their prescribing of controlled substances, and thus were more contented prescribing controlled substances.
2009年，佛罗里达州启动了一项全州范围的处方药监测计划（PDMP），以鼓励更安全地开具管制药品处方，并减少药物滥用和转移。支持此类计划在急诊科（ED）效用的数据很少。本研究旨在确定PDMP数据对急诊科管制药品处方的影响。
在这项采用历史对照的前后对照研究中，急诊科的药剂师为开处方者提供了其患者的PDMP数据摘要。将干预组开具的管制药品数量与历史对照组开具的数量进行比较，以确定干预是否导致管制药品平均开具数量发生变化。
在评估的710名患者中，向开处方者提供PDMP数据并未改变每位患者开具的管制药品平均数量（历史对照组为每位患者0.23种管制药品，干预组为每位患者0.28种管制药品；95%置信区间[CI]，-0.016至0.116；P = 0.125）。所有接受调查的开处方者均表示，有了PDMP数据改变了他们对管制药品的处方，并在开具管制药品时感觉更放心。
尽管结果并未表明在向开处方者提供PDMP数据时管制药品的平均开具数量有所变化，但调查结果表明，开处方者认为这些数据改变了他们对管制药品的处方，因此在开具管制药品时更满意。
